Skip to content Skip to footer

First Medicare-Accepted Oral Appliance Treatment for All Severities of Obstructive Sleep Apnea in Adults   LITTLETON, Colo., April 9, 2024 — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS),…

Call Scheduled for Thursday, August 12, 2021 at 5:00 pm ET HIGHLANDS RANCH   Colorado, August 9, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused…

The Vivos Institute Is Expected to Significantly Increase Vivos’ Ability to Educate Healthcare Providers on Ways to Help Millions of People Suffering from Sleep Apnea and its Comorbidities HIGHLANDS RANCH…

HIGHLANDS RANCH   Colorado, July 13, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for…

HIGHLANDS RANCH   Colorado, July 7, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for…

HIGHLANDS RANCH   Colorado, May 26, 2021 HIGHLANDS RANCH, Colo., May 26, 2021 – Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), HIGHLANDS RANCH, Colo., May 26, 2021 – Vivos Therapeutics,…

Management to Host Conference Call Today at 5:00 pm ET HIGHLANDS RANCH Colorado, May 17, 2021 HIGHLANDS RANCH, Colo., May 17, 2021 – Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS),…

Call Scheduled for Monday, May 17, 2021 at 5:00 pm ET HIGHLANDS RANCH   Colorado, March 13, 2021 HIGHLANDS RANCH, Colo., March 13, 2021 – Vivos Therapeutics, Inc. (“the Company”)…

HIGHLANDS RANCH   Colorado, May 11, 2021 Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients…

What’s Trending

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Tags